ALPS
Alps Group Inc
NASDAQ · Healthcare · Biotechnology · MY
$0.37
−2.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -5.48x
- Price / sales
- 18.26x
- Price / cash flow
- -38.27x
Enterprise value
- Enterprise value
- $67.1M
- EV / sales
- 19.91x
- EV / EBITDA
- -1.00x
- EV / EBIT
- -1.00x
- Market cap
- $61.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025